Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Please select a valid location from the dropdown

Found 704 clinical trials

Quality of Life and Psychological Well-being in Patients With Malignant Melanoma

The purpose of this study is to analyse the physical and psychological side-effects in the course of treatment with IFN-alpha. The effectiveness of a specific intervention for the management of these side-effects is evaluated.

12 views
08 Nov, 2020
1 location

Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)

Biomarkers search for early diagnosis of liver metastases in patients with uveal melanoma who benefit from a follow-up tailored to their personalized risk of relapse.

0 views
27 Jan, 2021
1 location

Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr

immunotherapy is not clear. Indeed, prolonged responses and long survivals have been described in patients having interrupted the treatment. In the melanoma, a treatment of 6 months of ipilimumab demonstrated

tumor cells

ipilimumab

gilbert's syndrome

liver metastasis

cancer

22 views
25 Jan, 2021
46 locations

Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)

This study will assess the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of escalating doses of quavonlimab when used in combination with pembrolizumab in participants with advanced solid tumors.

742 views
27 Jan, 2021
47 locations

SentoClone Compared to Reference Treatment in Advanced Malignant Melanoma

The purpose of this study is to elucidate whether SentoClone® gives improved treatment responses in patients with advanced malignant melanoma in comparison to established reference

temozolomide

metastasis

measurable disease

dacarbazine

14 views
08 Nov, 2020
5 locations

Intermittent Selumetinib for Uveal Melanoma

The purpose of this study is to find out what effects, good and/or bad, intermittent dosing of the drug Selumetinib will have on subjects with uveal melanoma. Selumetinib is a drug that blocks

spiral ct scan

karnofsky performance status

liver disease

measurable disease

alopecia

0 views
23 Jan, 2021
2 locations

Early FDG PET in Melanoma

Adult patients with histologically proven melanoma who will be treated with pembrolizumab will undergo FDG PET/CT scan as an early evaluation of response to therapy. Changes in FDG uptake will

7 views
24 Jan, 2021
1 location

Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma

TQB2450 is a humanized monoclonal antibody targeting programmed death ligand-1 (PD-L1), which prevents PD-L1 from binding to PD-1 and B7.1 receptors on T cell surface, restores T cell activity, thus enhancing immune response and has potential to treat various types of tumors.